Chromosomal instability causes sensitivity to metabolic stress

Oncogene

Volumn 34, Issue 31, 2015, Pages 4044-4055

  Shaukat, Z ^a   Liu, D ^a   Choo, A ^a   Hussain, R ^a   O'Keefe, L ^a   Richards, R ^a   Saint, R ^a   Gregory, S L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; FRUCTOSE BISPHOSPHATASE; GALACTOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE TRANSFERASE; MALATE DEHYDROGENASE (DECARBOXYLATING); MANGANESE SUPEROXIDE DISMUTASE; PEROXIREDOXIN; PEROXIREDOXIN 2; PHOSPHATE; PHOSPHOGLYCERATE MUTASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE DEHYDROGENASE; GLUTATHIONE;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL DEATH; CELL GROWTH; CELL STRESS; CELL SURVIVAL; CHROMOSOMAL INSTABILITY; DISEASE SEVERITY; HUMAN; LETHALITY; METABOLIC DISORDER; METABOLIC STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ANIMAL; ANIMAL EMBRYO; DNA DAMAGE; DROSOPHILA MELANOGASTER; GENETICS; LIPID PEROXIDATION; METABOLISM; NEOPLASM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; CHROMOSOMAL INSTABILITY; DNA DAMAGE; DROSOPHILA MELANOGASTER; EMBRYO, NONMAMMALIAN; GLUTATHIONE; LIPID PEROXIDATION; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STRESS, PHYSIOLOGICAL;

EID: 84938556302     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.344     Document Type: Article

References (68)

1. Mertens F, Mandahl N, Mitelman F, Heim S. Cytogenetic analysis in the examination of solid tumors in children. Pediatr Hematol Oncol 1994; 11: 361-377.
2. Weaver BA, Cleveland DW. Does aneuploidy cause cancer? Curr Opin Cell Biol 2006; 18: 658-667.
3. Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 2008; 180: 665-672.
4. Weaver B, Cleveland DW. Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res 2007; 67: 10103-10105.
5. Sotillo R, Schvartzman JM, Socci ND, Benezra R. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 2010; 464: 436-440.
6. Wassmann K, Benezra R. Mitotic checkpoints: from yeast to cancer. Curr Opin Genet Dev 2001; 11: 83-90.
7. Baker DJ, Jin F, Jeganathan KB, van Deursen JM. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 2009; 16: 475-486.
8. Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q et al. Chromosomal instability determines taxane response. Proc Natl Acad Sci USA 2009; 106: 8671-8676.
9. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006; 38: 1043-1048.
10. Shaukat Z, Wong HW, Nicolson S, Saint RB, Gregory SL. A screen for selective killing of cells with chromosomal instability induced by a spindle checkpoint defect. PLoS ONE 2012; 7: e47447.
11. Buffin E, Emre D, Karess RE. Flies without a spindle checkpoint. Nat Cell Biol 2007; 9: 565-572.
12. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
13. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 2009; 325: 1555-1559.
14. Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 2007; 178: 93-105.
15. Puzio-Kuter AM. The role of p53 in metabolic regulation. Genes Cancer 2011; 2: 385-391.
16. Pfau SJ, Amon A. Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep 2012; 13: 515-527.
17. Clem B, Telang S, Clem A, Yalcin A, Meier J, Simmons A et al. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 2008; 7: 110-120.
18. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 2010; 107: 2037-2042.
19. Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E et al. Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med 2010; 2: 31ra34.
20. Kaplan O, Navon G, Lyon RC, Faustino PJ, Straka EJ, Cohen JS. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism. Cancer Res 1990; 50: 544-551.
21. Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM et al. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 2009; 27: 3297-3302.
22. Gross S, Cairns RA, Minden MD, Driggers EM, Bittinger MA, Jang HG et al. Cancerassociated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 2010; 207: 339-344.
23. Holen K, Saltz LB, Hollywood E, Burk K, Hanauske A-R. The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Invest New Drugs 2008; 26: 45-51.
24. Schläfli P, Borter E, Spielmann P, Wenger RH. The PAS-domain kinase PASKIN: a new sensor in energy homeostasis. Cell Mol Life Sci 2009; 66: 876-883.
25. Hao H-X, Rutter J. The role of PAS kinase in regulating energy metabolism. IUBMB Life 2008; 60: 204-209.
26. O'Keefe L V, Colella A, Dayan S, Chen Q, Choo A, Jacob R et al. Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species. Hum Mol Genet 2011; 20: 497-509.
27. Stanton RC. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 2012; 64: 362-369.
28. Wong HW-S, Shaukat Z, Wang J, Saint R, Gregory SL. JNK signaling is needed to tolerate chromosomal instability. Cell Cycle 2013; 13: 1-10.
29. Iijima K, Zhao L, Shenton C, Iijima-Ando K. Regulation of energy stores and feeding by neuronal and peripheral CREB activity in Drosophila. PLoS ONE 2009; 4: e8498.
30. Hao H-X, Cardon CM, Swiatek W, Cooksey RC, Smith TL, Wilde J et al. PAS kinase is required for normal cellular energy balance. Proc Natl Acad Sci USA 2007; 104: 15466-15471.
31. Hockenbery DM. Targeting mitochondria for cancer therapy. Environ Mol Mutagen 2010; 51: 476-489.
32. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 2008; 18: 165-173.
33. Terhzaz S, Cabrero P, Chintapalli VR, Davies SA, Dow JT. Mislocalization of mitochondria and compromised renal function and oxidative stress resistance in Drosophila SesB mutants. Physiol Genomics 2010; 41: 33-41.
34. Radyuk SN, Rebrin I, Klichko VI, Sohal BH, Michalak K, Benes J et al. Mitochondrial peroxiredoxins are critical for the maintenance of redox state and the survival of adult Drosophila. Free Radic Biol Med 2010; 49: 1892-1902.
35. Sheltzer JM, Torres EM, Dunham MJ, Amon A. Transcriptional consequences of aneuploidy. Proc Natl Acad Sci USA 2012; 109: 12644-12649.
36. Coe JP, Rahman I, Sphyris N, Clarke AR, Harrison DJ. Glutathione and p53 independently mediate responses against oxidative stress in ES cells. Free Radic Biol Med 2002; 32: 187-196.
37. Wu D, Cederbaum AI. Oxidative stress mediated toxicity exerted by ethanolinducible CYP2E1. Toxicol Appl Pharmacol 2005; 207(2 Suppl): 70-76.
38. Owusu-Ansah E, Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009; 461: 537-541.
39. Miwa S, St-Pierre J, Partridge L, Brand MD. Superoxide and hydrogen peroxide production by Drosophila mitochondria. Free Radic Biol Med 2003; 35: 938-948.
40. Oromendia AB, Dodgson SE, Amon A. Aneuploidy causes proteotoxic stress in yeast. Genes Dev 2012; 26: 2696-2708.
41. Liu J, Wang X, Shigenaga MK, Yeo HC, Mori A, Ames BN. Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of rats. FASEB J 1996; 10: 1532-1538.
42. Tanaka T, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z. Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell Cycle 2008; 5: 1940-1945.
43. Janssen A, van der Burg M, Szuhai K, Kops GJ, Medema RH. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 2011; 333: 1895-1898.
44. Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 2012; 482: 53-58.
45. Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984; 12: 2137-2145.
46. Kops GJPL, Weaver B, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005; 5: 773-785.
47. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7: 11-20.
48. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
49. Li M, Fang X, Baker DJ, Guo L, Gao X, Wei Z et al. The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc Natl Acad Sci USA 2010; 107: 14188-14193.
50. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 2007; 317: 916-924.
51. Williams B, Prabhu V, Hunter K. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 2008; 322: 703-709.
52. Wang J, Yuan W, Chen Z, Wu S, Chen J, Ge J et al. Overexpression of G6PD is associated with poor clinical outcome in gastric cancer. Tumour Biol 2012; 33: 95-101.
53. Kuo W, Lin J, Tang TK. Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice. Int J Cancer 2000; 85: 857-864.
54. Zhang C, Zhang Z, Zhu Y, Qin S. Glucose-6-phosphate dehydrogenase: a biomarker and potential therapeutic target for cancer. Anticancer Agents Med Chem 2014; 14: 280-289.
55. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 2012; 9: e1001339.
56. Manganelli G, Masullo U, Passarelli S, Filosa S. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc Hematol Disord Drug Targets 2013; 13: 73-82.
57. Zhang J. Suppression of phosphoenolpyruvate carboxykinase gene expression by reduced endogenous glutathione level. Biochim Biophys Acta 2007; 1772: 1175-1181.
58. Cairns R, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11: 85-95.
59. Ren J-G, Seth P, Everett P, Clish CB, Sukhatme VP. Induction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2. PLoS ONE 2010; 5: e12520.
60. Beumer KJ, Trautman JK, Bozas A, Liu J-L, Rutter J, Gall JG et al. Efficient gene targeting in Drosophila by direct embryo injection with zinc-finger nucleases. Proc Natl Acad Sci USA 2008; 105: 19821-19826.
61. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603-1616.
62. Bauer G. Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling. Anticancer Res 2012; 32: 2599-2634.
63. Sajesh B V, Bailey M, Lichtensztejn Z, Hieter P, McManus KJ. Synthetic lethal targeting of superoxide dismutase 1 selectively kills RAD54B-deficient colorectal cancer cells. Genetics 2013; 195: 757-767.
64. Cheung-Ong K, Giaever G, Nislow C. DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. Chem Biol 2013; 20: 648-659.
65. Smart DK, Ortiz KL, Mattson D, Bradbury CM, Bisht KS, Sieck LK et al. Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. Cancer Res 2004; 64: 6716-6724.
66. Ozben T. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 2007; 96: 2181-2196.
67. Fang J, Nakamura H, Iyer AK. Tumor-targeted induction of oxystress for cancer therapy. J Drug Target 2007; 15: 475-486.
68. Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Cancer metabolism: new validated targets for drug discovery. Oncotarget 2013; 4: 1309-1316.